Liabilities / Assets
60th percentile
Higher debt load relative to assets than 60% of similar nonprofits.
Peptide Therapeutics Foundation
990EZ • Fiscal year 2022 • EIN 26-3728931
Siviq Scores
Precomputed percentiles for this filing year versus similar nonprofits in the same peer cohort.
0.00x
Liabilities / Revenue
63rd percentile
Higher debt load relative to revenue than 63% of similar nonprofits.
Net Margin
20th percentile
Higher net margin than 20% of similar nonprofits.
Top Officer Pay
78th percentile
Higher top officer pay than 78% of similar nonprofits.
Top officer pay equals 0.0% of source-year revenue.
Asset Growth
19th percentile
Faster asset growth than 19% of similar nonprofits.
Revenue Growth
78th percentile
Faster revenue growth than 78% of similar nonprofits.
Balance Sheet
Assets
Down$281,743
Down $91,957 (-25%) from 2021
Net Assets
Down$281,243
Down $92,260 (-25%) from 2021
Liabilities
Up$500
Up $303 (+154%) from 2021
Revenue And Expenses
Revenue
Up$110,022
Up $43,919 (+66%) from 2021
Expenses
Up$129,463
Up $13,554 (+12%) from 2021
Net Income
Up-$19,441
Up $30,365 (+61%) from 2021
Historical Trend
Jump To
Filing Snapshot
- Filing Period
- Jan 1, 2022 to Dec 31, 2022
- Signed
- May 23, 2023
- Return Version
- 2022v5.0
- Gross Receipts
- $110,022
Mission and Program Overview
Mission
The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.
Program Services
| Description | Grants | Expenses |
|---|---|---|
| HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. | - | $129,463 |
| PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. | - | - |
Compensation and Service Providers
Employees
| Name | Title | Full / Part Time | Base | Other | Total |
|---|---|---|---|---|---|
| NICK COX PHD | Associate Di | - | $0 | - | - |
| ADRIENNE DAY PHD | Treasurer An | - | $0 | - | - |
| ROBERT HAGOPIAN | Director Busines | - | $0 | - | - |
| LUTZ JERMUTUS | Senior Direc | - | $0 | - | - |
| ADAM MEZO PHD | Sr. Director | - | $0 | - | - |
| RIE SCHULTZ HANSEN PHD | SVP & Chief | - | $0 | - | - |
Filing and Contact Details
Filer
- Filer Name
- Peptide Therapeutics Foundation
- EIN
- 26-3728931
- Phone
- 8586571511
- Address
- 9395 CABOT DRIVE, SAN DIEGO, CA 92126
Signing Officer
- Name
- Adrienne Day Phd
- Title
- Treasurer and Director
- Phone
- 8586571511
- Signed
- 2023-05-23
Preparer
- Firm
- GOODSELL & COMPANY INC CPA'S
- Address
- 2366 FRONT STREET, SAN DIEGO, CA 92101-1414
- Preparer
- Steven J Holc CPA
- Phone
- 6192384343
Supplemental Narrative
Additional Explanations
Form 990-ez, Part I, Line 16
“Expenses office expenses 329 insurance 944 symposium expenses 101,275 foundation maintenance 20,903 dues & subscriptions 137 contract services 1,335 licenses & fees 705 total 125,628”
Form 990-ez, Part I, Line 20
“Unrealized loss on investments -72,819 unrealized loss on investments”
Form 990-ez, Part II, Line 26
“Accrued symposium expense 197 500”
Form 990-ez, Part III
“The mission of peptide therapeutics foundation is to provide and promote public and charitable educational and informational programs, materials, research and discussion in the medical scientific field of peptide science and technology.”
Form 990-ez, Part III, Line 28
“Hold a peptide therapeutics symposium to bring together world leaders from academia, the biopharmaceutical industry, cmos, cros, and investors interested in all aspects of peptide r&d, including drug discovery, safety and toxicology, clinical develoment, manufacturing, pharmaceutical development, formulation, drug delivery and regulatory affairs. The organization also provided 13 postdoctoral fellows and graduate students with free registration to the symposium.”
Form 990-ez, Part III, Line 31
“Peptide therapeutics has assets in an a brokerage firm. Expenses are related to the brokerage firm.”
Raw XML Appendix170 raw XML fields
This appendix keeps the raw XML leaves available for debugging and edge-case review. The human report above is the primary experience.
| Path | # | Value |
|---|---|---|
| IRS990EZ/ActivitiesNotPreviouslyRptInd | 0 | false |
| IRS990EZ/BooksInCareOfDetail/BusinessName/BusinessNameLine1Txt | 0 | THE ORGANIZATION |
| IRS990EZ/BooksInCareOfDetail/PhoneNum | 0 | 8586571511 |
| IRS990EZ/BooksInCareOfDetail/USAddress/AddressLine1Txt | 0 | 9395 CABOT DRIVE |
| IRS990EZ/BooksInCareOfDetail/USAddress/CityNm | 0 | SAN DIEGO |
| IRS990EZ/BooksInCareOfDetail/USAddress/StateAbbreviationCd | 0 | CA |
| IRS990EZ/BooksInCareOfDetail/USAddress/ZIPCd | 0 | 92126 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/BOYAmt | 0 | 373700 |
| IRS990EZ/CashSavingsAndInvestmentsGrp/EOYAmt | 0 | 281743 |
| IRS990EZ/ChgMadeToOrgnzngDocNotRptInd | 0 | false |
| IRS990EZ/DonorAdvisedFndsInd | 0 | false |
| IRS990EZ/EngagedInExcessBenefitTransInd | 0 | false |
| IRS990EZ/ExcessOrDeficitForYearAmt | 0 | -19441 |
| IRS990EZ/FeesAndOtherPymtToIndCntrctAmt | 0 | 3835 |
| IRS990EZ/FiledScheduleAInd | 0 | true |
| IRS990EZ/ForeignFinancialAccountInd | 0 | false |
| IRS990EZ/ForeignOfficeInd | 0 | false |
| IRS990EZ/Form1120PolFiledInd | 0 | false |
| IRS990EZ/Form990TotalAssetsGrp/BOYAmt | 0 | 373700 |
| IRS990EZ/Form990TotalAssetsGrp/EOYAmt | 0 | 281743 |
| IRS990EZ/GainOrLossFromSaleOfAssetsAmt | 0 | 1448 |
| IRS990EZ/GrossReceiptsAmt | 0 | 110022 |
| IRS990EZ/InfoInScheduleOPartIIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIIInd | 0 | X |
| IRS990EZ/InfoInScheduleOPartIInd | 0 | X |
| IRS990EZ/InvestmentIncomeAmt | 0 | 6065 |
| IRS990EZ/LobbyingActivitiesInd | 0 | false |
| IRS990EZ/MadeLoansToFromOfficersInd | 0 | false |
| IRS990EZ/MethodOfAccountingAccrualInd | 0 | X |
| IRS990EZ/NetAssetsOrFundBalancesBOYAmt | 0 | 373503 |
| IRS990EZ/NetAssetsOrFundBalancesEOYAmt | 0 | 281243 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/BOYAmt | 0 | 373503 |
| IRS990EZ/NetAssetsOrFundBalancesGrp/EOYAmt | 0 | 281243 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 0 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 1 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 2 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 3 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 4 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/AverageHrsPerWkDevotedToPosRt | 5 | 1.00 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 0 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 1 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 2 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 3 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 4 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/CompensationAmt | 5 | 0 |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 0 | NICK COX PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 1 | ADRIENNE DAY PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 2 | ROBERT HAGOPIAN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 3 | LUTZ JERMUTUS |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 4 | ADAM MEZO PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/PersonNm | 5 | RIE SCHULTZ HANSEN PHD |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 0 | ASSOCIATE DI |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 1 | TREASURER AN |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 2 | DIR. BUSINES |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 3 | SENIOR DIREC |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 4 | SR. DIRECTOR |
| IRS990EZ/OfficerDirectorTrusteeEmplGrp/TitleTxt | 5 | SVP & CHIEF |
| IRS990EZ/OperateHospitalInd | 0 | false |
| IRS990EZ/Organization501c3Ind | 0 | X |
| IRS990EZ/OrganizationDissolvedEtcInd | 0 | false |
| IRS990EZ/OrganizationHadUBIInd | 0 | false |
| IRS990EZ/OtherChangesInNetAssetsAmt | 0 | -72819 |
| IRS990EZ/OtherExpensesTotalAmt | 0 | 125628 |
| IRS990EZ/PartVIHghstPdCntrctProfSrvcTxt | 0 | NONE |
| IRS990EZ/PartVIOfCompOfHghstPdEmplTxt | 0 | NONE |
| IRS990EZ/PoliticalCampaignActyInd | 0 | false |
| IRS990EZ/PrimaryExemptPurposeTxt | 0 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990EZ/ProgramServiceRevenueAmt | 0 | 102509 |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 0 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/DescriptionProgramSrvcAccomTxt | 1 | PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. |
| IRS990EZ/ProgramSrvcAccomplishmentGrp/ProgramServiceExpensesAmt | 0 | 129463 |
| IRS990EZ/ProhibitedTaxShelterTransInd | 0 | false |
| IRS990EZ/RelatedOrganizationCtrlEntInd | 0 | false |
| IRS990EZ/SaleOfAssetsGrossAmt | 0 | 1448 |
| IRS990EZ/ScheduleBNotRequiredInd | 0 | X |
| IRS990EZ/SchoolOperatingInd | 0 | false |
| IRS990EZ/StatesWhereCopyOfReturnIsFldCd | 0 | CA |
| IRS990EZ/SubjectToProxyTaxInd | 0 | false |
| IRS990EZ/SumOfTotalLiabilitiesGrp/BOYAmt | 0 | 197 |
| IRS990EZ/SumOfTotalLiabilitiesGrp/EOYAmt | 0 | 500 |
| IRS990EZ/TanningServicesProvidedInd | 0 | false |
| IRS990EZ/TotalExpensesAmt | 0 | 129463 |
| IRS990EZ/TotalProgramServiceExpensesAmt | 0 | 129463 |
| IRS990EZ/TotalRevenueAmt | 0 | 110022 |
| IRS990EZ/TransactionWithControlEntInd | 0 | false |
| IRS990EZ/TrnsfrExmptNonChrtblRltdOrgInd | 0 | false |
| IRS990EZ/TypeOfOrganizationCorpInd | 0 | X |
| IRS990EZ/WebsiteAddressTxt | 0 | WWW.PEPTIDETHERAPEUTICS.ORG |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/ExplanationTxt | 0 | OTHER INCOME 2,618 |
| IRS990ScheduleA/Form990ScheduleAPartVIGrp/FormAndLineReferenceDesc | 0 | PART III, LINE 12 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus1YearAmt | 0 | 50160 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 43680 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 89945 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 89970 |
| IRS990ScheduleA/GiftsGrantsContrisRcvd509Grp/TotalAmt | 0 | 273755 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearAmt | 0 | 6065 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/CurrentTaxYearMinus1YearAmt | 0 | 6999 |
| IRS990ScheduleA/GrossInvestmentIncome509Grp/TotalAmt | 0 | 13064 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearAmt | 0 | 102509 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus1YearAmt | 0 | 20180 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus2YearsAmt | 0 | 6200 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus3YearsAmt | 0 | 31320 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/CurrentTaxYearMinus4YearsAmt | 0 | 35390 |
| IRS990ScheduleA/GrossReceiptsAdmissionsGrp/TotalAmt | 0 | 195599 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearAmt | 0 | 6065 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/CurrentTaxYearMinus1YearAmt | 0 | 6999 |
| IRS990ScheduleA/InvestmentIncomeAndUBTIGrp/TotalAmt | 0 | 13064 |
| IRS990ScheduleA/InvestmentIncomeCYPct | 0 | 0.03000 |
| IRS990ScheduleA/InvestmentIncomePYPct | 0 | 0.01000 |
| IRS990ScheduleA/OtherIncome509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 2618 |
| IRS990ScheduleA/OtherIncome509Grp/TotalAmt | 0 | 2618 |
| IRS990ScheduleA/PubliclySupportedOrg509a2Ind | 0 | X |
| IRS990ScheduleA/PublicSupportCY509Pct | 0 | 0.96770 |
| IRS990ScheduleA/PublicSupportPY509Pct | 0 | 0.98090 |
| IRS990ScheduleA/PublicSupportTotal509Amt | 0 | 469354 |
| IRS990ScheduleA/ThirtyThrPctSuprtTestsCY509Ind | 0 | X |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearAmt | 0 | 102509 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus1YearAmt | 0 | 70340 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus2YearsAmt | 0 | 49880 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus3YearsAmt | 0 | 121265 |
| IRS990ScheduleA/Total509Grp/CurrentTaxYearMinus4YearsAmt | 0 | 125360 |
| IRS990ScheduleA/Total509Grp/TotalAmt | 0 | 469354 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearAmt | 0 | 108574 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus1YearAmt | 0 | 77339 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus2YearsAmt | 0 | 49880 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus3YearsAmt | 0 | 121265 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/CurrentTaxYearMinus4YearsAmt | 0 | 127978 |
| IRS990ScheduleA/TotalSupportCalendarYearGrp/TotalAmt | 0 | 485036 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 0 | EXPENSES OFFICE EXPENSES 329 INSURANCE 944 SYMPOSIUM EXPENSES 101,275 FOUNDATION MAINTENANCE 20,903 DUES & SUBSCRIPTIONS 137 CONTRACT SERVICES 1,335 LICENSES & FEES 705 TOTAL 125,628 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 1 | UNREALIZED LOSS ON INVESTMENTS -72,819 UNREALIZED LOSS ON INVESTMENTS |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 2 | ACCRUED SYMPOSIUM EXPENSE 197 500 |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 3 | THE MISSION OF PEPTIDE THERAPEUTICS FOUNDATION IS TO PROVIDE AND PROMOTE PUBLIC AND CHARITABLE EDUCATIONAL AND INFORMATIONAL PROGRAMS, MATERIALS, RESEARCH AND DISCUSSION IN THE MEDICAL SCIENTIFIC FIELD OF PEPTIDE SCIENCE AND TECHNOLOGY. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 4 | HOLD A PEPTIDE THERAPEUTICS SYMPOSIUM TO BRING TOGETHER WORLD LEADERS FROM ACADEMIA, THE BIOPHARMACEUTICAL INDUSTRY, CMOS, CROS, AND INVESTORS INTERESTED IN ALL ASPECTS OF PEPTIDE R&D, INCLUDING DRUG DISCOVERY, SAFETY AND TOXICOLOGY, CLINICAL DEVELOMENT, MANUFACTURING, PHARMACEUTICAL DEVELOPMENT, FORMULATION, DRUG DELIVERY AND REGULATORY AFFAIRS. THE ORGANIZATION ALSO PROVIDED 13 POSTDOCTORAL FELLOWS AND GRADUATE STUDENTS WITH FREE REGISTRATION TO THE SYMPOSIUM. |
| IRS990ScheduleO/SupplementalInformationDetail/ExplanationTxt | 5 | PEPTIDE THERAPEUTICS HAS ASSETS IN AN A BROKERAGE FIRM. EXPENSES ARE RELATED TO THE BROKERAGE FIRM. |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 0 | FORM 990-EZ, PART I, LINE 16 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 1 | FORM 990-EZ, PART I, LINE 20 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 2 | FORM 990-EZ, PART II, LINE 26 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 3 | FORM 990-EZ, PART III |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 4 | FORM 990-EZ, PART III, LINE 28 |
| IRS990ScheduleO/SupplementalInformationDetail/FormAndLineReferenceDesc | 5 | FORM 990-EZ, PART III, LINE 31 |
| ReturnHeader/BuildTS | 0 | 2023-04-26 12:10:37Z |
| ReturnHeader/BusinessOfficerGrp/PersonNm | 0 | ADRIENNE DAY PHD |
| ReturnHeader/BusinessOfficerGrp/PersonTitleTxt | 0 | TREASURER AND DIR |
| ReturnHeader/BusinessOfficerGrp/PhoneNum | 0 | 8586571511 |
| ReturnHeader/BusinessOfficerGrp/SignatureDt | 0 | 2023-05-23 |
| ReturnHeader/Filer/BusinessName/BusinessNameLine1Txt | 0 | PEPTIDE THERAPEUTICS FOUNDATION |
| ReturnHeader/Filer/BusinessNameControlTxt | 0 | PEPT |
| ReturnHeader/Filer/EIN | 0 | 263728931 |
| ReturnHeader/Filer/PhoneNum | 0 | 8586571511 |
| ReturnHeader/Filer/USAddress/AddressLine1Txt | 0 | 9395 CABOT DRIVE |
| ReturnHeader/Filer/USAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/Filer/USAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/Filer/USAddress/ZIPCd | 0 | 92126 |
| ReturnHeader/IRSResponsiblePrtyInfoCurrInd | 0 | false |
| ReturnHeader/PreparerFirmGrp/PreparerFirmEIN | 0 | 331005644 |
| ReturnHeader/PreparerFirmGrp/PreparerFirmName/BusinessNameLine1Txt | 0 | GOODSELL & COMPANY INC CPA'S |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/AddressLine1Txt | 0 | 2366 FRONT STREET |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/CityNm | 0 | SAN DIEGO |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/StateAbbreviationCd | 0 | CA |
| ReturnHeader/PreparerFirmGrp/PreparerUSAddress/ZIPCd | 0 | 921011414 |
| ReturnHeader/PreparerPersonGrp/PhoneNum | 0 | 6192384343 |
| ReturnHeader/PreparerPersonGrp/PreparationDt | 0 | 2023-11-09 |
| ReturnHeader/PreparerPersonGrp/PreparerPersonNm | 0 | STEVEN J HOLC CPA |
| ReturnHeader/ReturnTs | 0 | 2023-11-09T15:27:59-05:00 |
| ReturnHeader/ReturnTypeCd | 0 | 990EZ |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonFirstNm | 0 | ADRIENNE |
| ReturnHeader/SigningOfficerGrp/PersonFullName/PersonLastNm | 0 | DAY PHD |
| ReturnHeader/TaxPeriodBeginDt | 0 | 2022-01-01 |
| ReturnHeader/TaxPeriodEndDt | 0 | 2022-12-31 |
| ReturnHeader/TaxYr | 0 | 2022 |
Document Assets
No mirrored PDF or thumbnail assets are attached yet.
Filings
Displayed year
2022 • Form 990EZDetailed filing. Detailed filing data is available for this year.
- Assets
- $281,743
- Liabilities
- $500
- Net assets
- $281,243
- Revenue
- $110,022
- Expenses
- $129,463
- Net income
- -$19,441